Scientists develop 'female Viagra' by accident

Experts have discovered the female equivalent of Viagra. Much like the original, Fibanserin was developed during clinical trials for what was intended to be anti depressant. Scientists found that whilst it proved to be an ineffective anti depressant, it did however increase the sexual appetite of female subjects, as well as their level of sexual satisfaction. Heading the studies was John Thorp from the University of North Carolina. Thorp claims that: "astute observers noted that it increased libido in laboratory animals and humans".

The study involved women aged 18 and older, all of whom had been diagnosed with ‘hypoactive sexual desire disorder’ (decreased libido). The female subjects were studied for 6 months.

Female sexual dysfunction (or FSD) is a condition that actually affects a large proportion of the female population. The majority of sufferers experience a severe decrease in their sex drive. This can often pose a strain on relationships and distress on the part of the sufferer.

Viagra was initially unveiled over a decade ago, as a direct result of a series of trials into treatments for angina. However, Fibanserin has caused a great deal of debate amongst experts, some of whom feel that the makers of the drug are guilty of exaggerating the figures concerning the number of women who are actually suffering with FSD.

Other experts deem the treatment to be entirely unsuitable, given the lack of consideration for the psychological causes of low libidos, aside from the physical contributories. To date, there are a number of herbal alternatives to these medications, including the likes of V-RX Female; a natural concentration of beneficial ingredients, proven to help suffers of FSD.

Anybody suffering with sexual dysfunction is advised to seek the advice of a trained health practitioner.